Follow us on social media!
RADIANT
  • Home
    • Aims
    • Membership >
      • The RADiANT Team
      • Advisory Group
      • NHS Service Providers
      • Academic Members
  • Research
    • Current Research
    • Recent Publications
  • Staff Development
    • Free to Access Courses
  • Events
    • PD in ID series
    • 12 Month CPD Programme
    • Upcoming Events
    • Past Events
  • Public Education
    • Free to Access Courses
    • Coronavirus (Covid-19)
    • RADiANT Health Columns
    • Great Care Information Hub
  • RADiANT News and Blog
  • Contact

6 Month Programme on Personality Disorder in Intellectual Disability

RADiANT are hosting a series of six events focused on the diagnosis known as Personality Disorder in people with Intellectual Disability. To download the programme, click here.  These sessions are held on the last Friday of Every Month, 1-3pm, on Microsoft Teams. To be added to the monthly invitation list, please contact v.chester@nhs.net.  
Month 4 - Programme and Slides
PD, ID & ASD: Overlaps, Treatments and Outcomes
Verity Chester

PD & Developmental Disabilities: Key issues in Staff Training & Support 
Prof Regi Alexander

Month 3 - Programme and Slides
Risk assessments: HCR-20, DASA-4 and other instruments
Dr Phil Temple
 
Structured activities, Community participation and Transition planning
Ms Vicki Malcolm
 
Trauma-informed care
Dr Rachel Holt and Laura Jacobs 

Month 2 - Programme and Slides
Introducing the 10 point assessment and treatment programme: describing diagnostic formulation
Dr Phil Temple
 
Psychological formulation, PBS plan, other psychological and offence specific treatments 
Prof Peter Langdon
 
Use of medication
Prof Regi Alexander and Reena Tharian
Month 1 - Programme and Slides​
Personality disorders (PD) in Intellectual Disability (ID): Diagnostic reliability, validity and clinical utility, Categorical, dimensional and motivational models
Prof Regi Alexander
 
Trauma in Intellectual Disability secure services: A question of causality? Service, diagnostic and treatment implications from a series of adolescent and adult population studies
Dr Deborah Morris